5-(5-(5-carbamimidoylpyridin-2-yl)furan-2-yl)picolinimidamide

ID: ALA1650579

PubChem CID: 53324541

Max Phase: Preclinical

Molecular Formula: C16H14N6O

Molecular Weight: 306.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: DB1283 | CHEMBL1650579|DB1283

Canonical SMILES:  N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)nc3)o2)nc1

Standard InChI:  InChI=1S/C16H14N6O/c17-15(18)10-2-3-11(21-8-10)14-6-5-13(23-14)9-1-4-12(16(19)20)22-7-9/h1-8H,(H3,17,18)(H3,19,20)

Standard InChI Key:  WSEZUZSOMAOMKF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -3.7233  -16.4678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7245  -17.2954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0116  -17.7082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2922  -17.2948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2954  -16.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0135  -16.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5072  -16.2131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8425  -16.7016    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1724  -16.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4229  -15.4343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2479  -15.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5422  -16.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5463  -17.4521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2626  -17.8599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9753  -17.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9672  -16.6134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2503  -16.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6930  -17.8495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6995  -18.6745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4041  -17.4314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4396  -17.7068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1535  -17.2933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4408  -18.5318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  7  1  0
  5  6  2  0
  6  1  1  0
 12 13  2  0
  7  8  1  0
 13 14  1  0
  1  2  2  0
 14 15  2  0
  3  4  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  9 12  1  0
  4  5  1  0
 15 18  1  0
  2  3  1  0
 18 19  1  0
  8  9  1  0
 18 20  2  0
  9 10  2  0
  2 21  1  0
 10 11  1  0
 21 22  2  0
 11  7  2  0
 21 23  1  0
M  END

Associated Targets(non-human)

Trypanosoma evansi (198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.33Molecular Weight (Monoisotopic): 306.1229AlogP: 1.97#Rotatable Bonds: 4
Polar Surface Area: 138.66Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.98CX LogP: 0.43CX LogD: -2.86
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.43Np Likeness Score: -0.74

References

1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R..  (2009)  In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model.,  53  (12): [PMID:19786604] [10.1128/aac.00422-09]

Source